As of 2025-12-15, the Relative Valuation of Denali Therapeutics Inc (DNLI) is (76.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.98 USD, the upside of Denali Therapeutics Inc based on Relative Valuation is -524.6%.
The range of the Relative Valuation is (67.73) - (74.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.5x - 22.9x | 20.7x |
| Forward P/E multiples | 20.7x - 31.4x | 26.0x |
| Fair Price | (67.73) - (74.85) | (76.34) |
| Upside | -476.7% - -516.3% | -524.6% |
| Date | P/E |
| 2025-12-12 | -5.51 |
| 2025-12-11 | -5.32 |
| 2025-12-10 | -5.38 |
| 2025-12-09 | -6.02 |
| 2025-12-08 | -6.03 |
| 2025-12-05 | -6.11 |
| 2025-12-04 | -6.16 |
| 2025-12-03 | -5.82 |
| 2025-12-02 | -5.46 |
| 2025-12-01 | -5.56 |
| 2025-11-28 | -5.96 |
| 2025-11-26 | -5.94 |
| 2025-11-25 | -5.86 |
| 2025-11-24 | -5.80 |
| 2025-11-21 | -5.51 |
| 2025-11-20 | -5.25 |
| 2025-11-19 | -5.18 |
| 2025-11-18 | -5.35 |
| 2025-11-17 | -5.32 |
| 2025-11-14 | -5.34 |
| 2025-11-13 | -5.25 |
| 2025-11-12 | -5.36 |
| 2025-11-11 | -5.38 |
| 2025-11-10 | -4.78 |
| 2025-11-07 | -4.60 |
| 2025-11-06 | -4.41 |
| 2025-11-05 | -4.56 |
| 2025-11-04 | -4.57 |
| 2025-11-03 | -4.70 |
| 2025-10-31 | -4.99 |
| 2025-10-30 | -5.02 |
| 2025-10-29 | -4.98 |
| 2025-10-28 | -5.18 |
| 2025-10-27 | -4.96 |
| 2025-10-24 | -4.89 |
| 2025-10-23 | -4.86 |
| 2025-10-22 | -4.88 |
| 2025-10-21 | -5.19 |
| 2025-10-20 | -5.28 |
| 2025-10-17 | -5.10 |
| 2025-10-16 | -5.12 |
| 2025-10-15 | -4.99 |
| 2025-10-14 | -4.66 |
| 2025-10-13 | -4.59 |
| 2025-10-10 | -4.71 |
| 2025-10-09 | -4.95 |
| 2025-10-08 | -4.79 |
| 2025-10-07 | -4.56 |
| 2025-10-06 | -4.66 |
| 2025-10-03 | -4.72 |